BridgeBio Pharma (BBIO) Divestments (2021 - 2025)

BridgeBio Pharma has reported Divestments for 3 years, with the latest figure at $2.3 million in Q3 2025.

• Quarterly Divestments changed N/A year-over-year to $2.3 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (down 91.04% YoY) and the FY2025 annual result came in at $2.3 million, down 91.04% from the prior year.
• Divestments eased to $2.3 million in Q3 2025 per BBIO's latest filing, from $25.7 million in the prior quarter.
• Over five years, Divestments peaked at $29.4 million in Q4 2021 and troughed at $2.3 million in Q3 2025.
• A 3-year average of $19.1 million and a median of $25.7 million in 2024 frame the typical range for Divestments.